Andy O. Miller, MD is an Associate Attending Physician and Chief of Infectious Diseases at HSS as well as an Associate Professor of Clinical Medicine at Weill Cornell Medical College. Dr. Miller received his B.Sc. at Yale College and his MD at Harvard Medical School. He then trained in internal medicine at Columbia-Presbyterian and in infectious diseases at NYU.
From 2007 to 2010 Dr. Miller was an infectious diseases specialist at Bronx-Lebanon Hospital Center. He is the author of several peer-reviewed publications. Dr. Miller provides consultative and perioperative services to patients at HSS. He is developing clinical research programs to better prevent, diagnose, and treat infections in orthopedic patients, and in people with rheumatologic disease
Internal Medicine, Infectious Diseases
Bone and Joint Infections
Prosthetic Joint Infections
Infections in patients with rheumatologic conditions/new biological agents
General Infectious Diseases
Please call our office if you have questions regarding your insurance coverage. If you have out of network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Chief of Infectious Diseases, Hospital for Special Surgery
Associate Attending Physician, Hospital for Special Surgery
Associate Professor of Clinical Medicine, Weill Cornell Medical College
Member, Infectious Disease Society of America
Member, American Society of Microbiology
Member, Society for Healthcare Epidemiology
Member, Musculoskeletal Infection Society
Internal Medicine, 2004
Infectious Diseases, 2006
Harvard Medical School
Columbia-Presbyterian Medical Center
Columbia-Presbyterian Medical Center
NYU School of Medicine
English, Spanish, French
Radke EE, Brown SM, Pelzek AJ, Fulmer Y, Hernandez DN, Torres VJ, Thomsen IP, Chiang WK, Miller AO, Shopsin B, Silverman GJ. Hierarchy of human IgG recognition within the Staphylococcus aureus immunome. Sci Rep. 2018 Sep 5;8(1):13296. doi: 10.1038/s41598-018-31424-3. PubMed PMID: 30185867; PubMed Central PMCID: PMC6125462.
Lam A, Richardson SS, Buksbaum J, Markowitz J, Henry MW, Miller AO, Rozbruch SR, Fragomen AT. Chronic Osteomyelitis of the tibia and ankle treated with Limb Salvage Reconstruction. J Bone Jt Infect. 2019 Dec 10;4(6):306-313. doi: 10.7150/jbji.40337. eCollection 2019. PubMed PMID: 31966963; PubMed Central PMCID: PMC6960027.
Goodman SM, Nocon AA, Selemon NA, Shopsin B, Fulmer Y, Decker ME, Grond SE, Donlin LT, Figgie MP, Sculco TP, Russell LA, Henry ME, Bass AR, Miller AO, Sculco PK. Increased Staphylococcus aureus Nasal Carriage Rates in Rheumatoid Arthritis Patients on Biologic Therapy. J Arthroplasty. 2019 May;34(5):954-958.
Boyle KK, Kapadia M, Landy DC, Henry MW, Miller AO, Westrich GH. Utilization of Debridement, Antibiotics, and Implant Retention for Infection After Total Joint Arthroplasty Over a Decade in the United States. J Arthroplasty. 2020 Mar 21:S0883-5403(20)30277-1. doi: 10.1016/j.arth.2020.03.029. Epub ahead of print. PMID: 32279946.
Chalmers BP, Kapadia M, Chiu YF, Henry MW, Miller AO, Carli AV. Treatment and Outcome of Periprosthetic Joint Infection in Unicompartmental Knee Arthroplasty. J Arthroplasty. 2020 Jul;35(7):1917-1923. doi: 10.1016/j.arth.2020.02.036. Epub 2020 Feb 21. PMID: 32173618.
Miller AO, Kapadia M, Kirksey MA, Sandhu M, Jannat-Khah D, Bui T, Boyle KK, Krez A, Russell L, O'Neill J, Stein EM, Henry MW, Antao VC, Padgett DE. Clinical Experience with COVID-19 at a Specialty Orthopedic Hospital Converted to a Pandemic Overflow Field Hospital. HSS J. 2020 Aug 18;16(Suppl 1):1-7. doi: 10.1007/s11420-020-09779-z. Epub ahead of print. PMID: 32837415; PMCID: PMC7431310.
For more publications, please see the PubMed listing.
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of November 13, 2019, Dr. Miller reported no relationships with healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.